Home saliva tests could map Alzheimer's genetic risk across france
NCT ID NCT07679906
First seen Jul 01, 2026 · Last updated Jul 02, 2026 · Updated 1 time
Summary
This study aims to enroll 50,000 adults aged 45 and older in France to test for a gene called APOE, which is linked to Alzheimer's risk. Participants provide a saliva sample at home and complete online questionnaires. The goal is to build a large registry of genetic and health data to better understand who is at risk and to prepare for future prevention studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could create a national registry to identify people at high genetic risk for Alzheimer's, enabling future prevention trials and personalized strategies.
- What could go wrong
- This is an observational study, not a treatment trial. It will not directly prevent or treat Alzheimer's, and its success depends on large-scale participation and long-term follow-up.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
FIRALIS SA - Centre de Prélèvements Biologiques
RECRUITINGHuningue, 68330, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.